Answers are grounded in this paper and cite their sources.
The bottom-up assembly of prototissues from synthetic protocells provides a promising route for bridging artificial cell engineering with tissue-level functionality; however, integrating biochemical signaling with adaptive barrier properties within such systems remains challenging. Here, we construct skin-like prototissues by embedding catalytically active coacervate vesicle protocells within a gelatin–hydroxypropyltrimethylammonium chloride chitosan hydrogel. Within this architecture, spatially organized protocells act as confined microreactors that convert endogenous glucose into nitric oxide (NO), establishing a self-sustained pro-angiogenic NO signaling cascade. Concurrently, evaporation-driven surface reorganization generates an epidermis-like hydrophobic interface with antibacterial barrier function. The integration of protocell-mediated NO signaling with matrix-driven antibacterial barrier function yields emergent skin-like functionality. Leveraging this integrated design, the prototissues are configured as bioactive patches that markedly accelerate healing of bacterially infected diabetic wounds by promoting neovascularization while suppressing bacterial colonization. This work establishes a generalizable strategy for translating prototissue architectures into functional therapeutic interfaces.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: